Tirzepatide (Zepbound, Mounjaro) is a dual-agonist GLP-1 medication. It works like a GLP-1 agonist, but also targets a ...

GLP-1 weight loss drugs have quickly moved from medical journals to household conversations, reshaping how Americans think ...

Soaring in popularity, GLP-1 medications—from weekly injections to newly available pills—are rapidly reshaping how Americans ...

For the best results, medications like Ozempic and Zepbound should be combined with exercise and healthy eating habits.

GLP-1 medications have rapidly become some of the most influential treatments for Type 2 diabetes and weight loss. As more people look into these prescriptions, there is growing curiosity about how ...

GLP-1 drugs for weight loss are growing in popularity in the U.S. and across the world. Here's what some users say about their experiences with the medicines.

Ozempic maker's lawsuit, FDA enforcement could curtail sales of less expensive, compounded, versions of popular weight loss drugs.

As doctors learn why GLP-1s don't work for about 50% of people, they are also learning more about the complex drivers of obesity. They foresee a... GLP-1 drugs don't work for everyone. But ...

Bacteria in the gut may influence how GLP-1 receptor agonists work. This could help explain why patients do not respond equally to the same treatment. The post Your gut bacteria might affect how well ...

After gastric bypass surgery, 53‑year‑old Jennie Mixon reversed her Type 2 diabetes, shed half her body weight and reclaimed ...